酒精间隔消融
医学
梗阻性心肌病
心脏病学
内科学
肥厚性心肌病
烧蚀
梗阻性肥厚性心肌病
心肌病
金标准(测试)
心力衰竭
作者
Tolga Aksu,Tümer Erdem Güler,Kıvanç Yalın,Şükriye Ebru Gölcük,Kazım Serhan Özcan
标识
DOI:10.14744/anatoljcardiol.2016.7100
摘要
Septal reduction therapy is accepted as a first therapeutic option for symptomatic drug-resistant hypertrophic obstructive cardiomyopathy (HOCM). Although, surgical septal myectomy is the gold standard method, alcohol septal ablation is a well-studied alternative approach in the patients with suitable anatomy. Endocardial septal ablation (ESA) therapy was relatively new defined modality and outcomes of the procedure were not clearly elucidated yet. We aimed to review the clinical aspects of ESA procedure and provide some historical background.
科研通智能强力驱动
Strongly Powered by AbleSci AI